In today’s recent session, 0.53 million shares of the Petmed Express, Inc (NASDAQ:PETS) have been traded, and its beta is 0.77. Most recently the company’s share price was $4.28, and it changed around -$0.99 or -18.79% from the last close, which brings the market valuation of the company to $88.44M. PETS at last check was trading at a discount to its 52-week high of $6.85, offering almost -60.05% off that amount. The share price’s 52-week low was $2.90, which indicates that the recent value has risen by an impressive 32.24% since then. We note from Petmed Express, Inc’s average daily trading volume that its 10-day average is 0.25 million shares, with the 3-month average coming to 267.04K.
Petmed Express, Inc stock received a consensus recommendation rating of Hold, based on a mean score of 4.00. If we narrow it down even further, the data shows that 1 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended PETS as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Petmed Express, Inc is expected to report earnings per share of 0 for the current quarter.
Petmed Express, Inc (NASDAQ:PETS) trade information
Instantly PETS has been showing red trend so far today with a performance of -18.79% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.58 on recent trading dayincreased the stock’s daily price by 23.3%. The company’s shares are currently down -11.20% year-to-date, but still down -12.83% over the last five days. On the other hand, Petmed Express, Inc (NASDAQ:PETS) is -10.27% down in the 30-day period. We can see from the shorts that 1.51 million shares have been sold at a short interest cover period of 5.78 day(s).
The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to increase their stock price by 38.86% from its current value. Analyst projections state that PETS is forecast to be at a low of $7 and a high of $19.
Petmed Express, Inc (PETS) estimates and forecasts
The year-over-year growth rate is expected to be -13.05%, down from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 62M in revenue for the current quarter. 1 analysts expect Petmed Express, Inc to make 68.63M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 66.5M and 67.95M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -6.77%. Forecasts for the next quarter put sales growth at 1.00%.
PETS Dividends
Petmed Express, Inc’s next quarterly earnings report is expected to be released in March. The average dividend yield for the past five years averaged 6.86 per year.
Petmed Express, Inc (NASDAQ:PETS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 16.81% of Petmed Express, Inc shares, and 46.29% of them are in the hands of institutional investors. The stock currently has a share float of 55.64%. Petmed Express, Inc stock is held by 123.0 institutions, with HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 6.3507% of the shares, which is about 1.3 million shares worth $5.25 million.
RENAISSANCE TECHNOLOGIES LLC, with 6.2001% or 1.26 million shares worth $5.12 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Federated Hermes MDT Small Cap Core Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 640.08 shares worth $2.75 million, making up 3.10% of all outstanding shares. On the other hand, Federated Hermes MDT Small Cap Core Fund held roughly 550.63 shares worth around $2.37 million, which represents about 2.66% of the total shares outstanding.
